Fludeoxyglucose F 18
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 2005
Approved
Approval ID
915b1f71-616d-4cd9-90a7-bc556736a3d1
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 17, 2020
Manufacturers
FDA
Decatur Memorial Hospital
DUNS: 046584991
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Fludeoxyglucose F 18
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code73410-003
Application NumberANDA204463
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fludeoxyglucose F 18
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 6, 2019
FDA Product Classification
INGREDIENTS (3)
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
FLUDEOXYGLUCOSE F-18Active
Quantity: 20 mCi in 1 mL
Code: 0Z5B2CJX4D
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT